SCHEMBL7780481

SCHEMBL7780481

COc1ccc2c(c1)C(=Cc1c[nH]c3ccc(OC)cc13)C(=O)N2

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 7/20 0.83
RET P07949 5/20 0.83
NTRK2 Q16620 4/20 0.83
KDR P35968 4/20 0.83
CDK7 P50613 4/20 0.83
NTRK3 Q16288 3/20 0.83
PDGFRB P09619 3/20 0.83
FLT3 P36888 3/20 0.83
AURKB Q96GD4 3/20 0.83
CLK4 Q9HAZ1 3/20 0.83
PRKD3 O94806 2/20 0.83
ABL1 P00519 2/20 0.83
LTK P29376 2/20 0.83
CSNK1A1 P48729 2/20 0.83
MAP2K1 Q02750 2/20 0.83
MST1R Q04912 2/20 0.83
ALK Q9UM73 2/20 0.83
MAP2K2 P36507 1/20 0.83
CDK8 P49336 1/20 0.83
SYK P43405 1/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5201825 0.92 NTRK1 (0.75) NTRK1RETNTRK2KDRCDK7
SCHEMBL8697609 0.92 NTRK1 (0.75) NTRK1RETNTRK2KDRCDK7
SCHEMBL5203073 0.92 NTRK1 (0.75) NTRK1RETNTRK2KDRCDK7
SCHEMBL5201532 0.91 NTRK1 (1.00) NTRK1RETNTRK2KDRCDK7
SCHEMBL14448937 0.91 NTRK1 (1.00) NTRK1RETNTRK2KDRCDK7
SCHEMBL5470614 0.91 NTRK1 (0.76) NTRK1RETNTRK2KDRCDK7
SCHEMBL14448947 0.91 NTRK1 (0.76) NTRK1RETNTRK2KDRCDK7
SCHEMBL5470617 0.91 NTRK1 (0.76) NTRK1RETNTRK2KDRCDK7
SCHEMBL5472269 0.91 NTRK1 (1.00) NTRK1RETNTRK2KDRCDK7
SCHEMBL8583226 0.89 SYK (0.82) NTRK1RETNTRK2KDRCDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0684820-B1 BIOLOGICALLY ACTIVE 3-SUBSTITUTED OXINDOLE DERIVATIVES USEFUL AS ANTI-ANGIOGENIC AGENTS PHARMACIA & UPJOHN SPA (IT) 2001-08-16 EP claimed
US-5409949-A Methylen-oxindole derivatives compositions and tyrosine kinase inhibition therewith FARMITALIA CARLO ERBA S.R.L. (IT) 1995-04-25 US claimed
EP-0552329-A1 METHYLEN-OXINDOLE DERIVATIVES AND PROCESS FOR THEIR PREPARATION PHARMACIA & UPJOHN S.p.A. (IT) 1993-07-28 EP claimed
EP-0525472-A2 Methylen-oxindole derivatives and process for their preparation PHARMACIA S.p.A. (IT) 1993-02-03 EP claimed
WO-1993001182-A1 METHYLEN-OXINDOLE DERIVATIVES AND PROCESS FOR THEIR PREPARATION FARMITALIA CARLO ERBA SRL (IT) 1993-01-21 WO claimed
EP-0552329-B1 METHYLEN-OXINDOLE DERIVATIVES AND PROCESS FOR THEIR PREPARATION PHARMACIA & UPJOHN SPA (IT) 2001-10-04 EP disclosed
US-5409949-A Methylen-oxindole derivatives compositions and tyrosine kinase inhibition therewith FARMITALIA CARLO ERBA S.R.L. (IT) 1995-04-25 US disclosed
EP-0552329-A1 METHYLEN-OXINDOLE DERIVATIVES AND PROCESS FOR THEIR PREPARATION PHARMACIA & UPJOHN S.p.A. (IT) 1993-07-28 EP disclosed
EP-0525472-A2 Methylen-oxindole derivatives and process for their preparation PHARMACIA S.p.A. (IT) 1993-02-03 EP disclosed
WO-1993001182-A1 METHYLEN-OXINDOLE DERIVATIVES AND PROCESS FOR THEIR PREPARATION FARMITALIA CARLO ERBA SRL (IT) 1993-01-21 WO disclosed